Incentives and Integrity in Healthcare

This chapter examines the challenges of incentivizing healthcare professionals, particularly doctors, to prioritize patient well-being over financial gain. It highlights the significant influence of pharmaceutical companies on medical practices and decision-making, using the controversial Alzheimer's drug Adjahelm as a case study. The discussion raises critical questions about the interplay between profit motives and patient care, calling for a reevaluation of trust in medical institutions.